Tolerance induction with FTY720 and donor-specific blood transfusion: discrepancy between heart transplantation and intestinal transplantation.
Koshiba
T
T
Abdominal Transplant Surgery Anatomopathology and Experimental Transplant Laboratory, KU, Leuven, Belgium.
Ji
P
P
Tanaka
K
K
McMaster
P
P
Van Damme
B
B
Waer
M
M
Pirenne
J
J
D000818:Animals; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007421:Intestine, Small / Q000637:transplantation*; D008297:Male; D011409:Propylene Glycols / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013110:Sphingosine / Q000031:analogs & derivatives; D015996:Survival Rate; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology*
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine